digraph "In hepatocellular carcinoma ,  biomarker analysis in Phase II clinical trials showed a clear correlation between levels of phospho-ERK and clinical response ,  suggesting that inhibition of Raf kinase is responsible for part of the clinical benefit ( Abou-Alfa et al. ,  2006 ) ,  but in the other indications ,  it appears likely that inhibition of vascular endothelial growth factor receptor 2 or other kinases is responsible ." {
label="In hepatocellular carcinoma ,  biomarker analysis in Phase II clinical trials
showed a clear correlation between levels of phospho-ERK and clinical response ,
suggesting that inhibition of Raf kinase is responsible for part of the clinical
benefit ( Abou-Alfa et al. ,  2006 ) ,  but in the other indications ,  it
appears likely that inhibition of vascular endothelial growth factor receptor 2
or other kinases is responsible .";
carcinoma3 [style=filled, fillcolor=white, label=carcinoma];
hepatocellular2 [style=filled, fillcolor=white, label=hepatocellular];
carcinoma3 -> hepatocellular2  [label=nn];
showed12 [style=filled, fillcolor=white, label=showed];
showed12 -> carcinoma3  [label=prep_in];
analysis6 [style=filled, fillcolor=white, label=analysis];
biomarker5 [style=filled, fillcolor=white, label=biomarker];
analysis6 -> biomarker5  [label=nn];
showed12 -> analysis6  [label=nsubj];
trials11 [style=filled, fillcolor=white, label=trials];
Phase8 [style=filled, fillcolor=white, label=Phase];
trials11 -> Phase8  [label=nn];
II9 [style=filled, fillcolor=white, label=II];
trials11 -> II9  [label=nn];
clinical10 [style=filled, fillcolor=white, label=clinical];
trials11 -> clinical10  [label=amod];
analysis6 -> trials11  [label=prep_in];
showed12 -> showed12  [label=root];
correlation15 [style=filled, fillcolor=white, label=correlation];
a13 [style=filled, fillcolor=white, label=a];
correlation15 -> a13  [label=det];
clear14 [style=filled, fillcolor=white, label=clear];
correlation15 -> clear14  [label=amod];
showed12 -> correlation15  [label=dobj];
levels17 [style=filled, fillcolor=white, label=levels];
correlation15 -> levels17  [label=prep_between];
response22 [style=filled, fillcolor=white, label=response];
"phospho-ERK19" [style=filled, fillcolor=white, label="phospho-ERK"];
response22 -> "phospho-ERK19"  [label=amod];
clinical21 [style=filled, fillcolor=white, label=clinical];
"phospho-ERK19" -> clinical21  [label=conj_and];
levels17 -> response22  [label=prep_of];
suggesting24 [style=filled, fillcolor=white, label=suggesting];
showed12 -> suggesting24  [label=vmod];
responsible31 [style=filled, fillcolor=white, label=responsible];
that25 [style=filled, fillcolor=white, label=that];
responsible31 -> that25  [label=mark];
inhibition26 [style=filled, fillcolor=white, label=inhibition];
responsible31 -> inhibition26  [label=nsubj];
kinase29 [style=filled, fillcolor=white, label=kinase];
Raf28 [style=filled, fillcolor=white, label=Raf];
kinase29 -> Raf28  [label=nn];
inhibition26 -> kinase29  [label=prep_of];
is30 [style=filled, fillcolor=white, label=is];
responsible31 -> is30  [label=cop];
suggesting24 -> responsible31  [label=ccomp];
part33 [style=filled, fillcolor=white, label=part];
responsible31 -> part33  [label=prep_for];
benefit37 [style=filled, fillcolor=white, label=benefit];
the35 [style=filled, fillcolor=white, label=the];
benefit37 -> the35  [label=det];
clinical36 [style=filled, fillcolor=white, label=clinical];
benefit37 -> clinical36  [label=amod];
part33 -> benefit37  [label=prep_of];
"Abou-Alfa39" [style=filled, fillcolor=white, label="Abou-Alfa"];
benefit37 -> "Abou-Alfa39"  [label=appos];
"al.41" [style=filled, fillcolor=white, label="al."];
"Abou-Alfa39" -> "al.41"  [label=conj_et];
200643 [style=filled, fillcolor=white, label=2006];
"Abou-Alfa39" -> 200643  [label=dep];
indications50 [style=filled, fillcolor=white, label=indications];
the48 [style=filled, fillcolor=white, label=the];
indications50 -> the48  [label=det];
other49 [style=filled, fillcolor=white, label=other];
indications50 -> other49  [label=amod];
appears53 [style=filled, fillcolor=white, label=appears];
appears53 -> indications50  [label=prep_in];
it52 [style=filled, fillcolor=white, label=it];
appears53 -> it52  [label=nsubj];
showed12 -> appears53  [label=conj_but];
likely54 [style=filled, fillcolor=white, label=likely];
appears53 -> likely54  [label=acomp];
responsible68 [style=filled, fillcolor=white, label=responsible];
that55 [style=filled, fillcolor=white, label=that];
responsible68 -> that55  [label=mark];
inhibition56 [style=filled, fillcolor=white, label=inhibition];
responsible68 -> inhibition56  [label=nsubj];
receptor62 [style=filled, fillcolor=white, label=receptor];
vascular58 [style=filled, fillcolor=white, label=vascular];
receptor62 -> vascular58  [label=nn];
endothelial59 [style=filled, fillcolor=white, label=endothelial];
receptor62 -> endothelial59  [label=nn];
growth60 [style=filled, fillcolor=white, label=growth];
receptor62 -> growth60  [label=nn];
factor61 [style=filled, fillcolor=white, label=factor];
receptor62 -> factor61  [label=nn];
inhibition56 -> receptor62  [label=prep_of];
263 [style=filled, fillcolor=white, label=2];
receptor62 -> 263  [label=dep];
kinases66 [style=filled, fillcolor=white, label=kinases];
other65 [style=filled, fillcolor=white, label=other];
kinases66 -> other65  [label=amod];
receptor62 -> kinases66  [label=conj_or];
is67 [style=filled, fillcolor=white, label=is];
responsible68 -> is67  [label=cop];
appears53 -> responsible68  [label=ccomp];
}
